AbCellera Biologics Inc. (ABCL)
Total Valuation
ABCL has a market cap or net worth of $1.66 billion. The enterprise value is $921.22 million.
| Market Cap | 1.66B |
| Enterprise Value | 921.22M |
Important Dates
The next estimated earnings date is Tuesday, February 20, 2024, after market close.
| Earnings Date | Feb 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 290.17 million shares outstanding. The number of shares has decreased by -8.33% in one year.
| Shares Outstanding | 290.17M |
| Shares Change (YoY) | -8.33% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 28.18% |
| Owned by Institutions (%) | 44.51% |
| Float | 192.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 27.47 |
| PS Ratio | 32.88 |
| Forward PS | 29.28 |
| PB Ratio | 1.40 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.34, with a Debt / Equity ratio of 0.06.
| Current Ratio | 8.34 |
| Quick Ratio | 7.69 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -37.77 |
Financial Efficiency
Return on equity (ROE) is -10.70% and return on invested capital (ROIC) is -16.61%.
| Return on Equity (ROE) | -10.70% |
| Return on Assets (ROA) | -8.50% |
| Return on Capital (ROIC) | -16.61% |
| Revenue Per Employee | $79,987 |
| Profits Per Employee | -$204,986 |
| Employee Count | 630 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -27.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.18% in the last 52 weeks. The beta is 0.28, so ABCL's price volatility has been lower than the market average.
| Beta (1Y) | 0.28 |
| 52-Week Price Change | -43.18% |
| 50-Day Moving Average | 4.71 |
| 200-Day Moving Average | 5.94 |
| Relative Strength Index (RSI) | 63.04 |
| Average Volume (30 Days) | 1,566,201 |
Short Selling Information
The latest short interest is 26.42 million, so 9.11% of the outstanding shares have been sold short.
| Short Interest | 26.42M |
| Short Previous Month | 27.00M |
| Short % of Shares Out | 9.11% |
| Short % of Float | 13.76% |
| Short Ratio (days to cover) | 15.56 |
Income Statement
In the last 12 months, ABCL had revenue of $50.39 million and -$129.14 million in losses. Loss per share was -$0.45.
| Revenue | 50.39M |
| Gross Profit | 50.39M |
| Operating Income | -208.93M |
| Pretax Income | -156.84M |
| Net Income | -129.14M |
| EBITDA | -115.65M |
| EBIT | -152.80M |
| Loss Per Share | -$0.45 |
Balance Sheet
The company has $810.84 million in cash and $75.19 million in debt, giving a net cash position of $735.66 million or $2.54 per share.
| Cash & Cash Equivalents | 810.84M |
| Total Debt | 75.19M |
| Net Cash | 735.66M |
| Net Cash Per Share | $2.54 |
| Equity / Book Value | 1.18B |
| Book Value Per Share | 4.08 |
| Working Capital | 809.28M |
Cash Flow
In the last 12 months, operating cash flow was $6.65 million and capital expenditures -$74.85 million, giving a free cash flow of -$68.20 million.
| Operating Cash Flow | 6.65M |
| Capital Expenditures | -74.85M |
| Free Cash Flow | -68.20M |
| FCF Per Share | -$0.24 |
Margins
Gross margin is 100.00%, with operating and profit margins of -414.61% and -256.27%.
| Gross Margin | 100.00% |
| Operating Margin | -414.61% |
| Pretax Margin | -311.24% |
| Profit Margin | -256.27% |
| EBITDA Margin | -229.50% |
| EBIT Margin | -303.21% |
| FCF Margin | -135.34% |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -7.79% |
| FCF Yield | -4.12% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.33% |
| Shareholder Yield | 8.33% |
Analyst Forecast
The average price target for ABCL is $20.00, which is 250.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.00 |
| Price Target Difference | 250.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | -15.04% |
| EPS Growth Forecast (5Y) | -24.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 3.66 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.66 |
| Piotroski F-Score | 2 |